Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression
Apple Hit with Rare Sell Rating, J&J's Ketamine-Derived Nasal Spray Gets FDA Approved for Depression  
Podcast: The Rundown
Published On: Tue Jan 21 2025
Description: Stock market update for January 21, 2025. Check out our Instagram account @TheRundownDaily